Sienna Biopharmaceuticals, Inc. – Further to Disappointing Auction and Pre-Petition Lender's Refusal to Extend Access to Cash Collateral, Debtor Seeks Conversion to Chapter 7 | Daily Bankrupt Company Updates Bankrupt Company News
